Perceval S sutureless valve for aortic valve replacement a review of the clinical effectiveness, safety, and cost-effectiveness
The Perceval S sutureless valve consists of a bioprosthetic valve mounted on a self-expanding nitinol stent. It received European regulatory approval in January 2013, and is currently undergoing US registration trials. In Canada it is available on a named-patient basis through the Health Canada spec...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
29 January 2015, 2015
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The Perceval S sutureless valve consists of a bioprosthetic valve mounted on a self-expanding nitinol stent. It received European regulatory approval in January 2013, and is currently undergoing US registration trials. In Canada it is available on a named-patient basis through the Health Canada special access program. This report reviews the evidence for the effectiveness, safety and cost effectiveness for the Perceval S sutureless valve for patients with aortic stenosis |
|---|---|
| Item Description: | "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (33 pages) |